Home Cart Sign in  
Chemical Structure| 1937-19-5 Chemical Structure| 1937-19-5

Structure of Aminoguanidine HCl
CAS No.: 1937-19-5

Chemical Structure| 1937-19-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Aminoguanidine HCl is a selective and irreversible iNOS inhibitor.

Synonyms: Pimagedine hydrochloride; GER-11; Guanylhydrazine hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Aminoguanidine HCl

CAS No. :1937-19-5
Formula : CH7ClN4
M.W : 110.55
SMILES Code : NNC(N)=N.[H]Cl
Synonyms :
Pimagedine hydrochloride; GER-11; Guanylhydrazine hydrochloride
MDL No. :MFCD00039074
InChI Key :UBDZFAGVPPMTIT-UHFFFAOYSA-N
Pubchem ID :2734687

Safety of Aminoguanidine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-468 cells 1 mM 24-48 hours To study the effect of NOS2 inhibition on cell migration and biomarker expression, results showed AG suppressed NOS2 expression and activity. Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6323-8.
MDA-MB-231 cells 1 mM 24-48 hours To study the effect of NOS2 inhibition on cell migration and biomarker expression, results showed AG suppressed NOS2 expression and activity. Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6323-8.
MCF-7 cells 1 mM 24-48 hours To study the effect of NOS2 inhibition on cell migration and biomarker expression, results showed AG suppressed NOS2 expression and activity. Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6323-8.
Mouse C8-B4 microglial cells 10 μM 24 hours Aminoguanidine, an iNOS inhibitor, abolished the lipopolysaccharide and IFNγ-induced decrease in cell viability. Anesthesiology. 2009 Sep;111(3):566-73.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice MDA-MB-231-GFP breast cancer xenograft model Oral administration in drinking water 0.5 g/L Continuous administration for 37 days To study the effect of NOS2 inhibition on tumor growth and metastasis, results showed AG significantly reduced tumor growth and metastasis. Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6323-8.
Tg2576 mice Alzheimer's disease model Subcutaneous injection 20 mg/ml Once daily for 3 months To investigate the inhibitory effect of aminoguanidine on glycated Aβ formation and its impact on cognitive function, results showed that aminoguanidine significantly reduced levels of AGEs and Aβ, and improved spatial learning and memory in mice. Cell Death Dis. 2013 Jun 13;4(6):e673
Mice Endothelial-specific GR knockout mice (GREC KO) Intraperitoneal injection 15 mg/kg Administered at +2, +6, +24, and +30 hours after LPS treatment To evaluate the protective effect of aminoguanidine against LPS-induced sepsis. Results showed that aminoguanidine significantly improved the survival rate of GREC KO mice, nearly to 100%. Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):306-11.
C57BL/6J mice STZ-induced diabetic model Tail vein injection 100 mg/kg/day Once daily for three days Aminoguanidine significantly attenuated aortic hydrogen peroxide (H2O2) production in diabetic aortas but had only a marginal effect on reducing aortic superoxide (O2?-) production. The endothelium-dependent vasodilatation was modestly but significantly improved by AG, likely due to AG-induced reduction in hypercontractility. In endothelium-denuded diabetic aortas, NAD(P)H oxidase (NOX)-dependent O2?- production was completely attenuated by AG. Cardiovasc Diabetol. 2009 Dec 30;8:65

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

9.05mL

1.81mL

0.90mL

45.23mL

9.05mL

4.52mL

90.46mL

18.09mL

9.05mL

References

 

Historical Records

Categories